Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain perception of darbepoetin injection devices in chronic kidney disease
ACTRN12611000839909Phase 4Active, not recruiting
- Sponsor
- Department of Health
- Start
- Jul 2009
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of darbepoetin alfa in Uraemic Anaemia (2 arms), sponsored by Department of Health. Primary endpoint: Participant preference and recommendation for device. Started Jul 2009; status: active, not recruiting.
02
Drugs
darbepoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ACTRN12611000839909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000839909.